Track Abeona Therapeutics's current assets ($180M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Abeona Therapeutics (ABEO) currently reports a current assets of $180M as of March 2026. That compares with $88M in the prior-year period — up 107.7% year over year. Use the charts on this page to explore Abeona Therapeutics's current assets history and peer comparisons.
Abeona Therapeutics's current assets increased from $88M to $180M — a 107.7% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Abeona Therapeutics reported $180M in current assets as of March 2026. That compares with $88M in the prior-year period — up 107.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current assets of $180M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Abeona Therapeutics, and consider following ABEO for alerts when major investors trade the stock.
Abeona Therapeutics is classified in the Healthcare sector. On current assets, it currently shows $180M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ABEO with unrelated industries.